Showing results (451-460 of 514) with videos related to

Sort By:
Pageof 52
Nature Communications|March 13, 2021
PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2Sean A Murphy, Matthew Miyamoto, Anaïs Kervadec, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2024
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort studyMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2024
Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseStine Johansen, Simon Langkjær, Ditlev Nytoft Rasmussen, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Clinical and Vaccine Immunology : CVI|July 11, 2006
Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatmentKonstantin P Lyashchenko, Rena Greenwald, Javan Esfandiari, et al.
Plos One|July 31, 2009
Signal regulatory protein alpha (SIRPalpha) cells in the adaptive response to ESAT-6/CFP-10 protein of tuberculous mycobacteriaW Ray Waters, Mitchell V Palmer, Brian J Nonnecke, et al.
International Forum of Allergy & Rhinology|May 13, 2024
Patterns of virtual reality and Fitbit wearable activity device use after skull base surgeryVivek C Pandrangi, Ana Araujo, Michelle Buncke, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2018
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection TrialSara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
The Journal of Clinical Investigation|December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionPhilana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Pageof 52